2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
54
Unknown
19
Recruiting
16
Active not recruiting
10
Terminated
9
Not yet recruiting
2
Enrolling by invitation
2
Withdrawn
1
Suspended
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
549
Neoplasms
384
Carcinoma, Non-Small-Cell Lung
319
Colorectal Neoplasms
290
Lung Neoplasms
239
Prostatic Neoplasms
219
Carcinoma, Hepatocellular
212
Stomach Neoplasms
158
Pancreatic Neoplasms
151
Leukemia, Myeloid, Acute
139
Multiple Myeloma
130
Uterine Cervical Neoplasms
127
Recurrence
116
Rectal Neoplasms
112
Ovarian Neoplasms
105
Neoplasm Metastasis
104
Squamous Cell Carcinoma of Head and Neck
97
Head and Neck Neoplasms
89
Esophageal Neoplasms
85
Triple Negative Breast Neoplasms
84
Glioblastoma
80
Small Cell Lung Carcinoma
79
Endometrial Neoplasms
79
Colonic Neoplasms
78
Brain Neoplasms
78
Melanoma
69
Precursor Cell Lymphoblastic Leukemia-Lymphoma
66
Hematologic Neoplasms
64
Glioma
62
Motor Activity
60
Interventions
enoxaparin sodium
1
Injections
1
Dalteparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Digestive System Diseases
×
Clear all
NCT07556835
2026-04-29
BILIVER
Azienda USL Toscana Centro
Not yet recruiting
1,000 enrolled
NCT06153394
2024-04-23
PRIORITY
Western University, Canada
Phase 3
Not yet recruiting
50 enrolled